A 62-year-old patient with type 2 diabetes and an eGFR of 25 mL/min/1.73m² is currently taking metformin 1g twice daily. According to NICE guidelines, what action should be recommended?
-
A
Continue metformin at the current dose as it remains effective
-
B
Discontinue metformin as eGFR is below 30 mL/min/1.73m²
-
C
Increase the dose to improve glycaemic control
-
D
Switch to gliclazide only if HbA1c is above 58 mmol/mol